RGFR ~ CEO Shareholder

New Post Public Reply Private Reply Replies (0) Message Board
Big Tuna
1,096
RGFR ~ CEO Shareholder Update

http://www.stockhouse.com/news/press-releases...ess-update

SOUTHLAKE, Texas, Oct. 09, 2017 (GLOBE NEWSWIRE) -- Rangeford Resources, Inc. (“Rangeford”) (OTCQB:RGFR) today issued the following Special Letter to Shareholders from it Chief Executive Officer Thomas E. Lindholm.

Dear Shareholders:

It is hard to assess the progress of a major transformation from a single year’s results; but when you look back after a few years, it becomes clear just how much has changed. Before I offer a broader perspective, let me describe how we progressed despite the well-known downturn in the oil and gas industry.

While over-leveraged oil and gas companies have struggled to maintain enterprise value and many have taken bankruptcy as their only solution, Rangeford has withstood the economic storm. Going forward, we believe we there will be a low commodity price environment, and we must adapt to prosper in this new reality. Matter of fact, we took significant steps last year to stabilize our corporate situation and exited the legacy projects after reviewing each project’s economic viability. This process was time consuming but necessary.

Why would anyone take a position in Rangeford Resources knowing the state of the industry?

The answer is the FUTURE. We can’t control the commodity markets or past actions but we sure can plan and execute an operating plan that will report profitable operations and will position Rangeford for new opportunities.

What are the key drivers for Rangeford to succeed?

PEOPLE – We’re biased but we believe the USA has the top oil and gas professionals in the world. After stabilizing our corporate situation in 2017, we added two experienced professionals: Greg Cox, chief technology officer and geoscientist, and John Lepin, controller. We now have the fundamental elements in terms of the ability to access, acquire, and develop projects that we did not have before.
TECHNOLOGY – With the addition of Greg Cox who previously was the EVP of Exploration and Senior Geologist at Remington Oil and Gas, we intend to leverage the use of extensive databases, well logs, and historical records to evaluate the opportunities where new drilling and completion technologies could be applied to maximize future production results. For example, we have reviewed and evaluated over ten thousand wells in Texas alone and have identified thirty “high-value wells” that we intend to acquire.
STRATEGIC RELATIONSHIPS – Our president and chief operating officer, Marc Duncan has broadened Rangeford relationships with strong technical support from the University of Texas – Bureau of Economic Geology. Marc has also been in discussions with several interested parties in Mexico, Canada, and Colombia. We have many groups eager to work with and support us.
LOWER DRILLING AND OPERATING COSTS – Despite low oil and gas prices, we have adjusted and are prepared to bring strong ROI returns to our oil and gas properties. With our project underwriting standards, low overhead corporate structure, and re-negotiated oil field service contracts, we believe we can operate profitably at today’s oil prices. This is our new reality.
Now well positioned, Rangeford’s vision is to identify profitable oil and gas reserves and drilling opportunities. As of the end of September 2017, Rangeford has executed four letters of intent/offer sheets and continues to negotiate for new acquisitions. We will not chase over-priced plays and complex geological exploration. We’re confident we will build a solid portfolio of producing oil and gas properties with appropriate project funding.

Respecting our delinquent SEC filings, our Controller, John Lepin, has completed our financial statements and is working with our new Auditor, LBB & Associates, L.L.C. of Houston, Texas. When the audit is complete, we intend to prepare and file the required SEC 10-K and 10-Q filings.

We were asked recently “What is it that Rangeford Resources does not have?” Marc Duncan responded, “We don’t have many things…like bank debt, junk bonds, high overhead, litigation, operating problems, declining production, and bad attitudes!”

We are now positioned to take advantage of opportunities. The stock market will reward those oil and gas companies that can operate profitably in the current environment. We’ll achieve profitable operations with great people, low operating costs, and efficient drilling capital expenditures that are justified by economic producing oil wells.

Finally, we’d like express our appreciation for your support and patience while we formed a solid foundation to build a profitable oil and gas company for our shareholders. We invite you visit our website at www.rangeford-resources.com for press releases, SEC filings, and updates on our progress building Rangeford into the company that can compete and operate profitably in today’s environment

About Rangeford Resources, Inc.

Rangeford Resources, Inc. is a Texas-based, oil and gas exploration and production company. For further information on Rangeford, please visit our website www.rangeford-resources.com.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 313

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 193

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 128

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 130

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 224

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 332

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 134

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 541

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 161

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading

Top 5 Most Recently Viewed Articles

Phreesia Announces Q3 Fiscal Year 2025 Financial Results

Updated Category News Views 71

Phreesia to Release Fiscal Q3 2025 Results Soon Phreesia, Inc. (NYSE: PHR) has great news for its stakeholders! The company revealed plans to announce its financial results for the third quarter of fiscal year 2025 right after market closing on a Monday in December. During this quarter, the firm experienced substantial growth and is eager to share the details with the...

Continue Reading
Innovative Water Bowl Design Enhances Pet Hydration Experience

Updated Category News Views 374

Revolutionary Pet Water Bowl Crafted for Optimal Hydration Every pet owner knows the importance of keeping their furry friends hydrated, especially during hot days. A new invention promises to enhance the experience for pets and their owners alike. This innovative water bowl, known as the THERMA DRINK, is designed with features that cater directly to pet needs. The idea...

Continue Reading
HPH's Leadership Changes Signify Strategic Direction Ahead

Updated Category News Views 177

Leadership Transitions at HPH Highest Performances Holdings Inc. (NASDAQ: HPH) has recently seen a notable change in its Board of Directors. The company announced that Mr. Peh Chin Hua's tenure as Director has come to an end, effective immediately. This decision is part of a broader strategy aimed at strengthening the Board's overall composition and capabilities. Current...

Continue Reading
Apranga Group Reports Growth in Retail Turnover for 2025

Updated Category News Views 132

Apranga Group Retail Performance Overview for 2025 Apranga Group, a major player in the retail sector, has announced its impressive financial performance for the first six months of 2025, demonstrating notable growth compared to the prior year. The company's retail turnover reached a commendable EUR 166.1 million, reflecting a 2.8% increase from the same period in 2024....

Continue Reading
IMUNON Unveils Promising New Vaccine Data for COVID-19

Updated Category News Views 154

New Vaccine Insights from IMUNON's Phase 1 Clinical Trial The innovative PlaCCine technology platform developed by IMUNON, Inc. (NASDAQ: IMNN) promises remarkable durability and advantages over traditional mRNA vaccines, particularly in the struggle against COVID-19. Robust Results from IMNN-101 Vaccine Trials In an encouraging announcement, IMUNON shared pivotal data...

Continue Reading